PharVision Advisers’s Kilroy Realty KRC Stock Holding History

PharVision Advisers’s Portfolio KRC Stock Details KRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,521	Closed	-$318K	–	393
2025 Q4	$318K	Buy	+8,521	New	+$348K	0.16%	238

Other funds holding KRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RIM

Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

AAMU

APG Asset Management US New York $14.3B AUM 16.79% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PharVision Advisers's KRC Position: Q1 2026 in Review

PharVision Advisers sold out of Kilroy Realty (KRC) in Q1 2026, closing a stake of 8,521 shares — an estimated $318K sold.

PharVision Advisers first reported a position in KRC in Q4 2025 and held it in 1 quarter. The position peaked at $318K in Q4 2025. 342 funds tracked by Wall St. Rank hold KRC as of Q1 2026.

PharVision Advisers reported no remaining Kilroy Realty position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 8,521 Kilroy Realty shares in Q1 2026, an estimated $318K.
PharVision Advisers first reported a position in Kilroy Realty in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Kilroy Realty position peaked at $318K in Q4 2025.
342 funds tracked by Wall St. Rank held Kilroy Realty as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.